Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar explainstuff (99.25) Submitted: 12/16/2011 10:12:33 PM : Outperform Start Price: $2.38 SVNT Score: -72.16

Market Maker Selling phase soon?

Featured Broker Partners


Advertisement